ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

INCY Incyte Corporation

57.31
-0.14 (-0.24%)
25 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Incyte Corporation INCY NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.14 -0.24% 57.31 10:00:00
Open Price Low Price High Price Close Price Previous Close
57.56 57.19 57.78 57.31 57.45
more quote information »

Recent News

Date Time Source Heading
22/5/202403:15BWIncyte Expands Presence in Delaware through Acquisition of..
21/5/202422:00BWIncyte to Present at Upcoming Investor Conference
16/5/202411:45BWIncyte präsentiert Daten aus seinem Onkologie-Portfolio beim..
16/5/202401:44BWIncyte présentera les données de son portefeuille..
16/5/202401:10EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
15/5/202407:00BWIncyte to Highlight Data From its Oncology Portfolio at the..
14/5/202423:05IHMARKETNEWSProducer Price Inflation Data May Weigh On Wall Street
14/5/202408:06EDGAR2Form SC 13D/A - General statement of acquisition of..
14/5/202406:34IHMARKETNEWSDow Snaps Eight-Day Winning Streak After Lackluster Session
14/5/202401:19EDGAR2Form SC TO-I - Tender offer statement by Issuer
13/5/202421:19EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/5/202421:18EDGAR2Form 8-K - Current report
13/5/202421:00BWIncyte Announces Intention to Buy Back up to $2.0 Billion of..
10/5/202408:40EDGAR2Form SC 13D/A - General statement of acquisition of..
10/5/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/5/202422:00BWIncyte to Present at Upcoming Investor Conference
30/4/202421:00BWIncyte Reports 2024 First Quarter Financial Results and..
24/4/202408:11BWIncyte annonce l'acquisition d'Escient Pharmaceuticals et de..
24/4/202408:01BWIncyte gibt Übernahme von Escient Pharmaceuticals und dessen..
23/4/202421:00BWIncyte Announces Acquisition of Escient Pharmaceuticals and..
11/4/202422:00BWIncyte to Report First Quarter Financial Results
01/4/202423:30BWIncyte and CMS Announce Collaboration and License Agreement..
30/3/202407:30BWIncyte Reports Inducement Grant Under Nasdaq Listing Rule..
11/3/202423:57BWIncyte annonce de nouvelles données de l’étude de phase 2..
11/3/202421:06BWIncyte présente de nouvelles données de l’étude de phase 2..
11/3/202420:53BWIncyte legt neue brandaktuelle Daten aus Phase-2-Studie zur..
11/3/202407:05BWIncyte Announces New Data from Phase 2 Study Evaluating..
05/3/202406:38BWDe nouvelles données dérivées du portefeuille dermatologique..
05/3/202406:02BWNeue Daten aus dem wachsenden Dermatologieportfolio von..
05/3/202400:00BWNew Data from Incyte’s Growing Dermatology Portfolio to be..
01/3/202402:19BWIncyte Launches The Unseen Journey to Elevate the Hidden..
29/2/202423:30GLOBEKnight Therapeutics Announces Launch of Minjuvi® in Brazil
29/2/202401:11BWIncyte annonce que la Food and Drug Administration des..
28/2/202423:15BWIncyte gibt bekannt, dass die US-Arzneimittelbehörde FDA..
28/2/202408:08BWIncyte Announces U.S. Food and Drug Administration Grants..
17/2/202408:04EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
17/2/202404:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202404:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202404:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202404:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202404:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202404:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:00BWIncyte to Present at Upcoming Investor Conference
15/2/202404:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/2/202408:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/2/202423:03EDGAR2Form 8-K - Current report
13/2/202423:00BWIncyte Reports 2023 Fourth Quarter and Year-End Financial..
06/2/202420:08BWIncyte erhält exklusive weltweite Rechte für die Entwicklung..
06/2/202412:55BWIncyte obtient les droits exclusifs de développement et de..

Your Recent History

Delayed Upgrade Clock